Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (62) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter CMDh final position (3) Apply CMDh final position filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 30 referrals Remove Article 30 referrals filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 20 procedures (7) Apply Article 20 procedures filter Article 107i procedures (6) Apply Article 107i procedures filter Article 29(4) referrals (1) Apply Article 29(4) referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (6) Apply PRAC-CHMP-EC filter PRAC-CMDh (4) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (6) Apply Centrally and nationally authorised products (mixed) filter Nationally authorised product(s) (8) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Revocation (1) Apply Revocation filter Risk minimisation measures (3) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (2) Apply Additional monitoring filter Generic (2) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

62 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter

Referral type Article 30 referrals Remove Article 30 referrals filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 31 referrals Remove Article 31 referrals filter

Referral safety status Yes Remove Yes filter

Sort by

List item

Referral: Gadolinium-containing contrast agents

gadodiamide, gadopentetic acid, gadobenic acid, gadoxetic acid, gadoteridol, gadobutrol, gadoteric acid, associated names: Omniscan, Magnevist, Magnegita, Gado-MRT ratiopharm, Primovist, MultiHance, Dotarem, ProHance, Gadovist, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 06/12/2010
List item

Referral: Norfloxacin

norfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 19/11/2008, Last updated: 24/07/2008
List item

Referral: Calcitonins

calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/11/2002, EC decision date: 12/06/2003, Last updated: 02/03/2004
List item

Referral: Loratadine

loratadine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004
List item

Referral: Celecoxib

celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Agreal

veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008
List item

Referral: Baxter dialysis solutions

Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 16/12/2011, Last updated: 20/11/2013
List item

Referral: Bicalutamide 150 mg

bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007
List item

Referral: Ergot-derived dopamine agonists

bromocriptine, cabergoline, dihydroergocryptine, lisuride, pergolide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 26/06/2008
List item

Referral: Etoricoxib

etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Piroxicam

piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008
List item

Referral: Modafinil

modafinil, associated names: Modasomil, Modiodal, Provigil, Vigil, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 27/01/2011, Last updated: 26/04/2011
List item

Referral: Sibutramine

Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 26/03/2001, Last updated: 13/12/2002
List item

Referral: Dienogest/ethinylestradiol-containing medicinal products indicated in acne

dienogest, ethinyl estradiol, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 22/03/2017, Last updated: 24/03/2017
List item

Referral: Valproate

valproic acid, valproate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 26/08/2010, Last updated: 29/04/2011
List item

Referral: Pholcodine

pholcodine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 17/02/2012, Last updated: 28/03/2012
List item

Referral: Etoricoxib

etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/02/2004, EC decision date: 28/04/2004, Last updated: 09/06/2004
List item

Referral: Metamizole containing medicinal products

metamizole, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2018, EC decision date: 20/03/2019, Last updated: 28/03/2019
List item

Referral: Rofecoxib

rofecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 09/06/2004
List item

Referral: Methylphenidate

methylphenidate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 27/05/2009, Last updated: 22/09/2010
List item

Referral: Celecoxib

celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 29/04/2004, Last updated: 09/06/2004
List item

Referral: Nimesulide

nimesulide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 20/01/2012, Last updated: 19/04/2012
List item

Referral: Lumiracoxib

lumiracoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Omega-3 acid ethyl esters - containing medicinal products for oral in use in secondary prevention after myocardial infarction

Omega-3 fatty acid ethyl esters, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2018, EC decision date: 06/06/2019, Last updated: 13/06/2019
List item

Referral: Ifosfamide solutions

ifosfamide, associated names: Ifosfamide Eg, Ifo-Cell, Ifo-Cell N, Ifo-Cell N 2000, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2021, EC decision date: 21/06/2021, Last updated: 19/07/2021

Load more

62 results

Referral: Gadolinium-containing contrast agents

Referral: Norfloxacin

Referral: Calcitonins

Referral: Loratadine

Referral: Celecoxib

Referral: Agreal

Referral: Baxter dialysis solutions

Referral: Bicalutamide 150 mg

Referral: Ergot-derived dopamine agonists

Referral: Etoricoxib

Referral: Piroxicam

Referral: Modafinil

Referral: Sibutramine

Referral: Dienogest/ethinylestradiol-containing medicinal products indicated in acne

Referral: Valproate

Referral: Pholcodine

Referral: Etoricoxib

Referral: Metamizole containing medicinal products

Referral: Rofecoxib

Referral: Methylphenidate

Referral: Celecoxib

Referral: Nimesulide

Referral: Lumiracoxib

Referral: Omega-3 acid ethyl esters - containing medicinal products for oral in use in secondary prevention after myocardial infarction

Referral: Ifosfamide solutions